- ES
- EN
15th National Research Competition in Life and Earth Sciences
Rare diseases
Senior Researcher : Patricio Fernández Silva
Research Centre or Institution : Facultad de Veterinaria. Universidad de Zaragoza
Diseases caused by OXPHOS defects occur primarily as neurological, muscular, cardiac or endocrine dysfunction and for the time being lack effective treatments. The group is testing gene therapy for these diseases using xenoexpression in mammalian enzyme replacement cells. Specifically, we propose the in vivo expression of AOX monopeptide oxidase and NDI1 alternative yeast dehydrogenase, both capable of reversing a defective phenotype caused by OXPHOS failures in cultures. The aim is to determine whether AOX is able to reverse embryo fatality in a mouse without respiratory complex IV (Cox10 / ). The possible compensation by AOX for the pathological phenotype in the muscle-specific Cox10-/- mouse will also be studied.
Activities related
Projects related
News related
Publications related
International Symposium Undiagnosed and rare diseases in children and adolescents: Translation to clinic and society Barcelona, Wednesday and Thursday, November 27 and 28, 2019 9:30 hours
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas

Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021